Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.29 USD | +1.12% | -4.22% | -0.11% |
May. 24 | UBS Adjusts Medtronic Price Target to $76 From $75, Maintains Sell Rating | MT |
May. 24 | Bernstein Adjusts Price Target on Medtronic to $96 From $97 | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 4.04 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.11% | 108B | C | ||
-5.56% | 181B | C+ | ||
-6.17% | 66.12B | A | ||
+2.64% | 50.65B | B- | ||
+6.58% | 43.11B | B- | ||
+4.91% | 41.3B | B+ | ||
+21.98% | 31.6B | B | ||
+14.45% | 25.03B | A- | ||
-5.81% | 24.16B | A- | ||
-4.35% | 23.95B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MDT Stock
- Ratings Medtronic plc